Beckman Coulter Life Sciences launch CytoFLEX nano flow cytometer
Beckman Coulter Life Sciences (IN, USA) has launched a new CytoFLEX nano flow cytometer for research use only that enables nanoparticle detection down to 40nm. The new machine has increased sensitivity to detect, quantitate and characterize nanoparticles. It provides a solution that lowers the limit of detection and increases resolution to characterize lower abundance targets in heterogeneous extracellular vesicle populations between 1µm and 40nm.
In the CytoFLEX nano flow cytometer, nanoparticles are introduced in a hydrodynamic-focused stream to the optical system composed of lasers and detectors. Then, the emitted signals are collected, digitalized and displayed by CytExpert, which is the instrument control software. The new machine is designed to reduce noise and reduce carryover issues to enable consistent instrument performance and reproducibility of results.
You may also be interested in:
- eBook: Flow cytometry in cancer therapy development
- Novel integrated laboratory equipment from BD that automates the complete sample preparation process of flow cytometry
- Standardized and automated workflows in flow cytometry: kick-start your engine of growth
Product Manager Matthew Goff, Beckman Coulter Life Sciences, commented:
“The CytoFLEX nano Flow Cytometer shatters the previous limits of detection capabilities, arming researchers with data they previously would have never been able to access. This can open new doors for researchers and enable breakthrough discoveries in our battle against a myriad of diseases. Extracellular vesicles can be found everywhere, and now researchers finally have a tool to see what has always been right in front of them. We listened to the needs of our customers to create an analytical crossroads by increasing sensitivity through enhanced fluidics, optics, and electronics.”
